This study is testing a new continuous glucose monitor called CareSens Air 3 in 32 adults with type 1 diabetes. The goal is to see how accurately it measures blood sugar levels compared to standard lab tests. Participants will wear the device for a short time while their blood su…
Phase: NA • Sponsor: i-SENS, Inc. • Aim: Diagnosis
Last updated May 08, 2026 12:04 UTC